Cerebroplacental Ratio Better Guides Delivery With Perceived Less Fetal Movement
By Lori Solomon HealthDay Reporter

THURSDAY, July 17, 2025 -- An additional ultrasound measurement to assess resistance in fetal blood vessels can improve the decision of whether to expedite birth when a woman in the final stage of pregnancy perceives less fetal movements, according to a study published online July 10 in The Lancet Obstetrics, Gynaecology, & Women’s Health.
Laura A. Lens, M.D., from the University of Groningen in the Netherlands, and colleagues randomly assigned women with singleton pregnancies in the cephalic position with perceived reduced fetal movements at term to either cerebroplacental ratio (CPR)-based management (revealed group) or care as usual (concealed group). Expedited birth was performed for CPR <1.1 and expectant management for CPR ≥1.1. A total of 1,684 women were included in the analysis.
The researchers found that 12 percent of women who received CPR-based management and 15 percent of women who received care as usual experienced the composite of adverse perinatal outcomes (stillbirth, neonatal mortality [<28 days], five-minute Apgar score <7, umbilical artery pH <7.10, or emergency birth for fetal distress or severe neonatal morbidity [relative risk, 0.76]). There were no stillbirths, and there was one neonatal death in each group. There were 12 serious adverse events in the revealed group versus 14 in the concealed group. None of these adverse events were assessed as related to the study procedure by the local principal investigator, the medical ethics board of University Medical Centre Groningen, and the data safety monitoring board.
"If doctors know the CPR result, they can better determine whether reduced fetal movement is harmless or requires action," lead author Sanne J. Gordijn, M.D., Ph.D., also from the University of Groningen, said in a statement. "This ensures that both mother and baby receive the care best suited to their situation."
Several authors disclosed ties to relevant organizations.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-18 06:00
Read more

- Moderna’s New Flu Shot Shows Strong Results in Older Adults
- FDA Offers Speedier Approvals to Drug Companies Aligning With 'National Priorities'
- Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI
- FDA Halts New Clinical Trials That Export Americans’ Cells to Foreign Labs in Hostile Countries for Genetic Engineering
- FDA Publishes Full Texts of Response Letters to Drug Applications
- FDA Plans to Revoke 52 Food Standards
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions